There is a large number of bioactive polyketides well-known for their anticancer, antibiotic, cholesterol-lowering, and other therapeutic functions, and hispidin is among them. It is a highly abundant secondary plant and fungal metabolite, which is investigated in research devoted to cancer, metabolic syndrome, cardiovascular, neurodegenerative, and viral diseases. This review summarizes over 20 years of hispidin studies of its antioxidant, anti-inflammatory, anti-apoptotic, antiviral, and anti-cancer cell activity.
The fungal bioluminescence pathway can be reconstituted in other organisms allowing luminescence imaging without exogenously supplied substrate. The pathway starts from hispidin biosynthesis—a step catalyzed by a large fungal polyketide synthase that requires a posttranslational modification for activity. Here, we report identification of alternative compact hispidin synthases encoded by a phylogenetically diverse group of plants. A hybrid bioluminescence pathway that combines plant and fungal genes is more compact, not dependent on availability of machinery for posttranslational modifications, and confers autonomous bioluminescence in yeast, mammalian, and plant hosts. The compact size of plant hispidin synthases enables additional modes of delivery of autoluminescence, such as delivery with viral vectors.
Microbe–plant interactions are a cornerstone of sustainable agriculture, offering eco-friendly alternatives to synthetic fertilizers and pesticides. These benefits are not cost-free for the host, and maintaining mutualisms requires investments of carbon, ATP, macro- and micro-nutrients, and water. Many associations involve the formation of specialized symbiotic tissues and depend on extensive signaling and immune modulation to sustain compatibility. In this review, we synthesize current knowledge on plant–microbe interactions that enhance crop performance and evaluate the accompanying costs, framing them as a physiological and ecological trade-off.